Nurse Practitioner, Family · Gainesville, FL
NPI
1487827960
Since 2008
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1600 SW Archer Rd
Gainesville, FL, 32610
Phone (352) 273-9500
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
243 services
Medicare patients, 2024
184
Average age 69
Drug cost, 2024
$2.8M
487 prescriptions
Company payments, 2025
$26K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick M Horne was code 99214 (office e&m - established), 85 times for 66 patients. In total Patrick M Horne billed 243 services in 8 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 85 | 66 | $80.06 | $6,805 |
| 91200 Standard X-ray | Office | 72 | 70 | $17.03 | $1,226 |
| 99215 Office E&M - Established | Office | 31 | 31 | $83.08 | $2,575 |
| 99204 Office E&M - New | Office | 30 | 30 | $85.93 | $2,578 |
| 99205 Office E&M - New | Office | 21 | 21 | $144.35 | $3,031 |
By year: 2022 $20K for 285 services; 2023 $21K for 287 services; 2024 $16K for 243 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 30 | 24 | $8.40 | $252 |
Medicare prescription drug claims, 2024
In 2024, the drug Patrick M Horne prescribed most often to Medicare patients was Epclusa (Sofosbuvir/Velpatasvir), with 75 prescriptions and refills. In total Patrick M Horne wrote 487 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Epclusa Sofosbuvir/Velpatasvir | 75 | 75 | 28 | $1.8M |
| Sofosbuvir-Velpatasvir Sofosbuvir/Velpatasvir | 48 | 48 | 20 | $363K |
| Carvedilol Generic | 47 | 74 | 15 | $154 |
| Furosemide Generic | 37 | 71 | 14 | $113 |
| Lactulose Generic | 36 | 42 | Under 11 | $2,465 |
| Spironolactone Generic | 31 | 55 | 13 | $369 |
| Entecavir Generic | 30 | 38 | Under 11 | $1,118 |
| Azathioprine Generic | 19 | 55 | Under 11 | $740 |
| Vosevi Sofosbuvir/Velpatas/Voxilaprev | 18 | 18 | Under 11 | $429K |
| Tacrolimus Generic | 17 | 40 | Under 11 | $893 |
| Mycophenolate Mofetil Generic | 15 | 44 | Under 11 | $1,613 |
| Xifaxan Rifaximin | 13 | 13 | Under 11 | $39K |
| Ursodiol Generic | 11 | 21 | Under 11 | $667 |
| Mavyret Glecaprevir/Pibrentasvir | 11 | 11 | Under 11 | $137K |
| Ribavirin Generic | 11 | 11 | Under 11 | $688 |
Brand drugs: 181 claims; generic drugs: 306 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick M Horne $26K ($26K in general payments such as food, travel and fees) from 9 companies. The largest payer was Madrigal Pharmaceuticals with $9,529.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 21 | $9,529 |
| Abbvie Inc. ABBV | 12 | $5,131 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $2,996 |
| GlaxoSmithKline, LLC. GSK | 3 | $2,350 |
| Mirum Pharmaceuticals, Inc. MIRM | 5 | $1,552 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 6 | $1,520 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $1,264 |
| Intercept Pharmaceuticals, Inc. | 4 | $1,261 |
| Gilead Sciences, Inc. GILD | 3 | $108 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.